- Current languageen
Pharmaceuticals - Community Register
Community register of veterinary medicinal products
|Auth. number :||EU/2/12/144|
|Active substance :||Meloxicam|
|ATC:||Anatomical main group: QM - Musculo-skeletal system|
Therapeutic subgroup: QM01 - Antiinflammatory and antirheumatic products
Pharmacological subgroup: QM01A - Antiinflammatory and antirheumatic products, non-steroids
Chemical subgroup: QM01AC - Oxicams
Chemical substance: QM01AC06 - Meloxicam
(See WHO ATCvet Index)
For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in
For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of
over one week of age and young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy. For the relief of post-operative pain following dehorning in calves.
For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-
metritisagalactia syndrome) with appropriate antibiotic therapy. Horses: For use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.
For the relief of pain associated with equine colic.
|Marketing Authorisation Holder:||Zoetis Belgium S.A.
Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique
|EPAR and active package presentations|
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".|
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.
|Close date procedure||Procedure type||EMEA number||Decision||summary publ||decision docs||annex|
|11/12/2012||Centralised - Authorisation||EMEA/V/C/2612||(2012)9390 of 06/12/2012|
|11/04/2013||Centralised - Variation||EMEA/V/C/2612/II/1|
|Updated with Decision(2013)3818 of 13/06/2013|
|17/06/2013||Centralised - Transfer Marketing Authorisation Holder||EMEA/V/C/2612/T/3||(2013)3818 of 13/06/2013|
|27/09/2013||Centralised - Variation||EMEA/V/C/2612/IB/5|
|Updated with Decision(2014)312 of 16/01/2014|
|21/01/2014||Centralised - 2-Monthly update||EMEA/V/C/2612/IB/5||(2014)312 of 16/01/2014|
|17/02/2014||Centralised - Variation||EMEA/V/C/2612/X/2||(2014)1057 of 13/02/2014|
|10/07/2014||Centralised - Variation||EMEA/V/C/2612/IB/6|
|Updated with Decision(2015)5227 of 20/07/2015|
|23/07/2015||Centralised - Yearly update||(2015)5227 of 20/07/2015|